Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Growth

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 148.85-129.21-65.6056.89160.58

What is the latest Core EBITDA Growth ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Growth ratio of LASA SUPERGENERICS is 148.85 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024148.85
Mar2023-129.21
Mar2022-65.60
Mar202156.89
Mar2020160.58

How is Core EBITDA Growth of LASA SUPERGENERICS Trending?

Years Core EBITDA Growth % Change
Mar2024 148.85
Positive
Mar2023 -129.21
Negative
Mar2022 -65.6
Negative
Mar2021 56.89
-64.57
Mar2020 160.58 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Growth ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹75.2 Cr -12.1% -13.9% -36.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr 0.2% -8.3% 15.9% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -1.9% 8.6% 55.9% Stock Analytics
CIPLA ₹118,710.0 Cr -1.3% -5.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -0.5% -4.2% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.7% 5.8% 6.1% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-12.1%

-13.9%

-36.8%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses